What are the latest precision diagnostics for advanced melanoma

According to the NCCN Guidelines for Melanoma (2023), the key molecular diagnostic tests for advanced melanoma include:

1. BRAF Mutation Testing:

• Mandatory testing for all metastatic cases
• Tests for BRAF V600 mutations (most commonly V600E)
• Essential for determining eligibility for BRAF/MEK inhibitor therapy

1. Next-Generation Sequencing (NGS): The American Society of Clinical Oncology (ASCO) guidelines recommend comprehensive genomic profiling that includes testing for:

• NRAS mutations
• KIT mutations
• Other potentially actionable mutations
• Tumor mutational burden (TMB)

1. PD-L1 Testing: The National Cancer Institute (NCI) notes that while PD-L1 testing is available, it's not required before starting immunotherapy, as patients may respond regardless of PD-L1 status.

Additional Testing Recommendations: According to NCCN Guidelines:

• Molecular testing should be conducted on the most recent tissue sample when possible
• Testing should be performed in CLIA-certified laboratories
• Results should be available within 10 working days to guide treatment decisions

Always consult with your healthcare team about which tests are appropriate for your specific situation, as testing strategies may be individualized based on various clinical factors.